je.st
news
Medical Groups Question Price of New Hep C Drug
2014-03-11 19:47:51| Biotech - Topix.net
An innovative hepatitis C drug that was only recently hailed as a breakthrough treatment is facing skepticism from some health care providers, as they consider whether it is worth the $1,000-a-pill price set by manufacturer Gilead Sciences Inc. A panel of California medical experts voted Monday that Gilead's Sovaldi represents a "low value" ... (more)
Tags: price
question
groups
medical
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||